Skip to main content
Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
1.660
0.00 (0.00%)
At close: Nov 13, 2026, 4:00 PM EST
1.650
-0.010 (-0.60%)
After-hours: Nov 13, 2026, 7:30 PM EST

Xenetic Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.962.982.52.541.711.16
Revenue Growth
3.50%19.04%-1.56%48.80%47.06%165.64%
Gross Profit
2.962.982.52.541.711.16
Operating Income
-3.84-2.83-4.2-4.52-6.72-5.75
Net Income
-3.66-2.68-3.96-4.13-6.55-5.65
Earnings Per Share
-1.61-1.58-2.57-2.71-4.61-5.49
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
5.817.886.178.9813.118.24
Total Debt
-0.01---0.03
Net Cash (Debt)
5.817.886.178.9813.118.22
Net Cash Growth
40.96%27.76%-31.36%-31.41%-28.10%58.89%
Net Cash Per Share
2.554.634.005.889.2117.72

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.32-2.29-2.82-4.11-4.65-4.74
Capital Expenditures
------
Free Cash Flow
-2.32-2.29-2.82-4.11-4.65-4.74
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-129.63%-95.23%-168.16%-177.78%-393.57%-495.12%
Pretax Margin
-123.71%-90.07%-158.39%-162.78%-383.87%-486.36%
Profit Margin
-123.71%-90.07%-158.39%-162.78%-383.87%-486.36%
FCF Margin
-78.29%-76.83%-112.69%-161.98%-272.23%-408.21%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.371.672.462.092.5314.88